These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1364190)

  • 21. Decreased T cell response to mitogen and increased anti-cytoplasmic antibody in drug-free schizophrenic patients.
    Matloubi H; Vodjgani M; Nasehi AA; Niknam MH; Kazemnejad A; Salehi E; Aboufazeli T; Gheflati Z
    Iran J Immunol; 2007 Mar; 4(1):32-7. PubMed ID: 17652841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines in schizophrenia and the effects of antipsychotic drugs.
    Drzyzga L; Obuchowicz E; Marcinowska A; Herman ZS
    Brain Behav Immun; 2006 Nov; 20(6):532-45. PubMed ID: 16580814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables.
    Masserini C; Vita A; Basile R; Morselli R; Boato P; Peruzzi C; Pugnetti L; Ferrante P; Cazzullo CL
    Schizophr Res; 1990; 3(4):269-75. PubMed ID: 1980614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
    Maes M; Meltzer HY; Buckley P; Bosmans E
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspects of humoral and cellular immunity in schizophrenia.
    Vartanian ME; Kolyaskina GI; Lozovsky DV; Burbaeva GS; Ignatov SA
    Birth Defects Orig Artic Ser; 1978; 14(5):339-64. PubMed ID: 80239
    [No Abstract]   [Full Text] [Related]  

  • 26. Soluble interleukin 2 receptor levels in acute and stable schizophrenia.
    Gaughran F; O'Neill E; Sham P; Daly RJ; Shanahan F
    Schizophr Res; 2001 Oct; 52(1-2):143-4. PubMed ID: 11595403
    [No Abstract]   [Full Text] [Related]  

  • 27. [Psycho-immunological mechanisms in schizophrenia].
    Karanikas EP
    Psychiatriki; 2011; 22(1):43-52. PubMed ID: 21688524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy.
    Müller N; Hofschuster E; Ackenheil M; Eckstein R
    Acta Psychiatr Scand; 1993 Jan; 87(1):66-71. PubMed ID: 8093825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients.
    Theodoropoulou S; Spanakos G; Baxevanis CN; Economou M; Gritzapis AD; Papamichail MP; Stefanis CN
    Schizophr Res; 2001 Jan; 47(1):13-25. PubMed ID: 11163541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder.
    O'Donnell MC; Catts SV; Ward PB; Liebert B; Lloyd A; Wakefield D; McConaghy N
    Psychiatry Res; 1996 Dec; 65(3):171-8. PubMed ID: 9029665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern approaches to the study of immunity in schizophrenia].
    Koliaskina GI; Burbaeva GSh
    Vestn Akad Med Nauk SSSR; 1979; (7):76-84. PubMed ID: 395791
    [No Abstract]   [Full Text] [Related]  

  • 32. The behavior of T lymphocytes in schizophrenia.
    Liedeman RR; Prilipko LL
    Birth Defects Orig Artic Ser; 1978; 14(5):365-77. PubMed ID: 308380
    [No Abstract]   [Full Text] [Related]  

  • 33. Glutamine as an activator of immune cells: how does it work?
    Cynober L
    Nutrition; 1997; 13(7-8):688-9. PubMed ID: 9556357
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of immune function in schizophrenia: an overview.
    Müller N; Riedel M; Ackenheil M; Schwarz MJ
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():62-8. PubMed ID: 10654111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies against 60-kDa heat shock protein in schizophrenia.
    Schwarz MJ; Riedel M; Gruber R; Müller N; Ackenheil M
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(6):282-8. PubMed ID: 9928906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic-treated chronic schizophrenics.
    Monteleone P; Valente B; Maj M; Kemali D
    Biol Psychiatry; 1991 Jul; 30(2):201-4. PubMed ID: 1680471
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular immunity in schizophrenic patients before and during neuroleptic treatment.
    Müller N; Ackenheil M; Hofschuster E; Mempel W; Eckstein R
    Psychiatry Res; 1991 May; 37(2):147-60. PubMed ID: 1678892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A change of immune profile of patients with schizophrenia during treatment].
    Koliaskina GI; Sekirina TP; Androsova LV; Kushner SG; Vasil'eva EF; Burbaeva OA; Morozova MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):39-45. PubMed ID: 15270298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia.
    Yang ZW; Chengappa KN; Shurin G; Brar JS; Rabin BS; Gubbi AV; Ganguli R
    Psychol Med; 1994 May; 24(2):449-55. PubMed ID: 8084939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine production in unmedicated and treated schizophrenic patients.
    Rothermundt M; Arolt V; Leadbeater J; Peters M; Rudolf S; Kirchner H
    Neuroreport; 2000 Oct; 11(15):3385-8. PubMed ID: 11059907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.